We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA and EMA on the Same Page for Most Drug Approval Decisions, Analysis Shows
FDA and EMA on the Same Page for Most Drug Approval Decisions, Analysis Shows
A study by the FDA and EMA comparing their decisions on drug marketing applications found the two agencies align in most cases — but sometimes reach different conclusions about a drug’s efficacy.